Hughes, R. E., Elliott, R. J. R., Munro, A. F., Makda, A., O’Neill, J. R., Hupp, T., & Carragher, N. O. (2020). High-Content Phenotypic Profiling in Esophageal Adenocarcinoma Identifies Selectively Active Pharmacological Classes of Drugs for Repurposing and Chemical Starting Points for Novel Drug Discovery. SLAS Discov.

Hughes, Rebecca E., Richard J. R. Elliott, Alison F. Munro, Ashraff Makda, J. Robert O’Neill, Ted Hupp, a Neil O. Carragher. "High-Content Phenotypic Profiling in Esophageal Adenocarcinoma Identifies Selectively Active Pharmacological Classes of Drugs for Repurposing and Chemical Starting Points for Novel Drug Discovery." SLAS Discov 2020.

Hughes, Rebecca E., et al. "High-Content Phenotypic Profiling in Esophageal Adenocarcinoma Identifies Selectively Active Pharmacological Classes of Drugs for Repurposing and Chemical Starting Points for Novel Drug Discovery." SLAS Discov 2020.